Taken together, these results suggested that the sensitivity of cervical cancer cells to cisplatin could be increased by inhibiting SOX6-induced autophagy through both autophagy and MAP4K4 inhibitors. The gene discussed is MAP4K4; the disease is cervical carcinoma.